Skip to content
Precision for Medicine
Upcoming Webinar

Breaking Barriers with PCR: Innovative Solutions for Clinical Trial Success

false
Tai, Bibbs Avatar

Tai Bibbs

  • Read: Phase 1-2 Case Study: Oncology Trial Success and Proactive Partnership Phase 1-2 Case Study: Oncology Trial Success and Proactive Partnership

    Clinical Trials - Early Phase Research - Oncology

    Phase 1-2 Case Study: Oncology Trial Success and Proactive Partnership

    |
      has not third author: true, (SizeLimitingPyMap: {main={hs_id=169565849889, hs_child_table_id=0, hs_updated_at=1754641413972, hs_published_at=1754641637406, avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/tai-bibbs.png',altText='tai-bibbs',fileId=194123714175}, lastname=Bibbs, hs_initial_published_at=1718988967067, hs_created_by_user_id=26433386, hs_created_at=1717603645564, hs_is_edited=false, hs_deleted_at=0, name=Tai, job=Director, Project Management, slug=tai-bibbs, hs_updated_by_user_id=2737751}, second={}, third={}})
    • Tai Bibbs avatar

      Tai Bibbs

    Discover
  • Read: Case Study: Streamlining Radiopharmaceutical Clinical Trials Case Study: Streamlining Radiopharmaceutical Clinical Trials

    Oncology

    Case Study: Streamlining Radiopharmaceutical Clinical Trials

    |
      has not third author: true, (SizeLimitingPyMap: {main={hs_id=169565849889, hs_child_table_id=0, hs_updated_at=1754641413972, hs_published_at=1754641637406, avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/tai-bibbs.png',altText='tai-bibbs',fileId=194123714175}, lastname=Bibbs, hs_initial_published_at=1718988967067, hs_created_by_user_id=26433386, hs_created_at=1717603645564, hs_is_edited=false, hs_deleted_at=0, name=Tai, job=Director, Project Management, slug=tai-bibbs, hs_updated_by_user_id=2737751}, second={}, third={}})
    • Tai Bibbs avatar

      Tai Bibbs

    Discover
Loading...
You've reach the end